Chiron's Board Spurns Novartis Offer

FedEx to limit fuel surcharge; Prince Alwaleed bin Talal raises News Corp. stake; plus more of Tuesday's stocks in the news

Biopharmaceutical company Chiron's (CHIR ) board declared "inadequate" Novartis (NVS )'s offer to acquire its remaining 58% stake in Chiron for $40 per share.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.